Pubertad precoz masculina familiar (testotoxicosis): utilidad del tratamiento con ketoconazol y triptorelina
García García, Emilio; Álvarez del Vayo, Concepción; Castaño, Luis.
Med. clín (Ed. impr.)
; 159(11): e79-e80, diciembre 2022. tab
Artículo en Español | IBECS (España) | ID: ibc-213503
Documentos relacionados
A single blood sample for stimulated LH assayed by ICMA is useful for monitoring the treatment efficacy of triptorelin depot in girls.
Adult height after gonadotropin-releasing hormone agonist treatment in girls with early puberty: A meta-analysis.
Peak serum luteinising hormone cut-off during gonadotropin-releasing hormone analogue test for diagnosing central precocious puberty was lower in girls with obesity as compared with girls with normal weight.
[Considerations on the improvement of height benefit in children with central precocious puberty].
Diagnosis and management of precocious sexual maturation: an updated review.
[Further progress of the etiology,diagnosis and treatment of peripheral precocious puberty].
Early Puberty.
Gonadotropin-Releasing Hormone Analogs for Treatment of Central Precocious Puberty in Children Younger than 2 Years of Age.
Girls with idiopathic central precocious puberty did not display substatial changes in body mass index after treatment with gonadotropin-releasing hormone analogues.
Which parameters predict the beneficial effect of GnRHa treatment on height in girls with central precocious puberty?